489 related articles for article (PubMed ID: 19609919)
1. Axonal sensory motor neuropathy in copper-deficient Wilson's disease.
Foubert-Samier A; Kazadi A; Rouanet M; Vital A; Lagueny A; Tison F; Meissner W
Muscle Nerve; 2009 Aug; 40(2):294-6. PubMed ID: 19609919
[TBL] [Abstract][Full Text] [Related]
2. Copper deficiency in Wilson's disease: peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment.
Cortese A; Zangaglia R; Lozza A; Piccolo G; Pacchetti C
Mov Disord; 2011 Jun; 26(7):1361-2. PubMed ID: 21449011
[No Abstract] [Full Text] [Related]
3. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
4. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI
Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346
[TBL] [Abstract][Full Text] [Related]
5. [The role of zinc in the initial treatment of Wilson's disease in children].
Cacić M; Percl M; Jadresin O; Kolacek S
Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
[TBL] [Abstract][Full Text] [Related]
6. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
Sinha S; Taly AB
J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
[TBL] [Abstract][Full Text] [Related]
7. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
8. Video documented follow-up of liver transplantation in Wilson's disease with predominant neurological manifestation.
Suess T; Bokemeyer M; Schomerus G; Donnerstag F; Manns MP; Klempnauer J; Kolbe H; Weissenborn K
Mov Disord; 2007 May; 22(7):1036-8. PubMed ID: 17357135
[TBL] [Abstract][Full Text] [Related]
9. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic copper deficiency in three Wilson's disease patients treated with zinc sulphate.
Dzieżyc K; Litwin T; Sobańska A; Członkowska A
Neurol Neurochir Pol; 2014; 48(3):214-8. PubMed ID: 24981187
[TBL] [Abstract][Full Text] [Related]
11. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
Hoogenraad TU
Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and management of Wilson's disease: results of a single center experience.
Medici V; Trevisan CP; D'Incà R; Barollo M; Zancan L; Fagiuoli S; Martines D; Irato P; Sturniolo GC
J Clin Gastroenterol; 2006; 40(10):936-41. PubMed ID: 17063115
[TBL] [Abstract][Full Text] [Related]
13. Wilson's disease: appreciable improvement of sub-cortical white matter abnormalities after copper chelating treatment: five years follow-up.
Larnaout A; Ammar N; Mourad Z; Naji S; Hentati F
Neuropediatrics; 2008 Jun; 39(3):176-8. PubMed ID: 18991198
[TBL] [Abstract][Full Text] [Related]
14. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
15. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
16. [Current principles of Wilson's disease--diagnosis and treatment].
Najda J; Stella-Hołowiecka B; Machalski M; Woszczyk D; Mykała-Cieśla J
Wiad Lek; 2002; 55(9-10):600-7. PubMed ID: 12607416
[TBL] [Abstract][Full Text] [Related]
17. Results of treatment of Wilson's disease--own observations.
Jabłońska-Kaszewska I; Drobińska-Jurowiecka A; Dabrowska E; Trocha H
Med Sci Monit; 2003 Aug; 9 Suppl 3():9-14. PubMed ID: 15156603
[TBL] [Abstract][Full Text] [Related]
18. Low-dose zinc administration as an effective Wilson's disease treatment.
Najda J; Stella-Hołowiecka B; Machalski M
Biol Trace Elem Res; 2001 Jun; 80(3):281-4. PubMed ID: 11508632
[TBL] [Abstract][Full Text] [Related]
19. Trientine-induced neurological deterioration in a patient with Wilson's disease.
Kim B; Chung SJ; Shin HW
J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038
[TBL] [Abstract][Full Text] [Related]
20. Copper deficiency in Wilson's disease: an avoidable complication of treatment.
da Silva-Júnior FP; Lucato LT; Machado AA; Barbosa ER
Mov Disord; 2011 Nov; 26(13):2448-9; author reply 2449-50. PubMed ID: 21956703
[No Abstract] [Full Text] [Related]
[Next] [New Search]
